Genomics Market worth $19.0 Billion by 2018

                 Genomics Market worth $19.0 Billion by 2018

  PR Newswire

  DALLAS, January 27, 2014

DALLAS, January 27, 2014 /PRNewswire/ --

New analysis from MarketsandMarkets " Genomics Market  by Products -
[Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips,
Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing
& Microarray Services, and Software) - Global Forecast to 2018 ", finds that
the Global Genomics Market earned revenues of $11.11 billion in 2013 and
estimates this market to reach over $19.0 billion by 2018.

Browse 49 market data tables and 52 figures spread through 248 pages and
in-depth TOC on " Genomics Market"

http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html 

Early buyers will receive 10% customization on this report.

The report segments the Global Genomics Market by products (instrument,
consumables, and services), by technology (Nucleic acid extraction &
purification, PCR, DNA sequencing, and DNA microarray), by application
(diagnostics, personalized medicine, academic research, agriculture & animal
health, and academic research), and by geography (North America, Europe, APAC,
and RoW). Technological advancements (Nanopore sequencing, customized
microarray, and d-PCR), increasing capital investment by public and private
capitalists in genetic researches, as well as innovations in bioinformatics
tools for advanced application in drug discovery and academic research are
considered the key drivers for the global Genomics Market .

"The future of Genomics lies in the personalized medicine industry. Government
initiatives and considerable investments are expected to drive genetic
research on personalized medicines that utilize base pairs of the human genome
sequence", notes MarketsandMarkets Research Analyst.

As of now, the application of personalized medicine is primarily focused on
drug discovery for oncology, vaccine production, as well as infectious
disease-therapeutic areas. The usage and application areas for genomic
research in personalized medicine are expected to increase significantly in
coming years.

Over the last decade, Tier I and Tier II companies were found to be dominant
in the instruments and consumables product segments of the Genomics Market.
Moreover, increasing market consolidation through consecutive restructuring
activities by leading players has proved to be a challenge for new entrants.
"Market penetration in the Genomics services sub-segment would be a suitable
strategy for start-ups. Increasing dependency of small and medium scale
research institutes on outsourced services is expected to drive the market
significantly," concludes Antan. "Partnering with Tier I and Tier II
manufacturers reduces the initial capital investment, and allows small scale
service providers to leverage established brand names for market
penetration."Leading market players in this market include Roche Diagnostic
(Switzerland), Life Technologies, Corp. (U.S.), QIAGEN (Netherlands),
Illumina, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).

The Global Genomics Market study is part of the Biotechnology subscription
title, which also includes research in the following markets: Next Generation
Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies
Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq),
(Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global
Forecast to 2017, and Proteomics Market (Protein Microarray, Mass
Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface
Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services -
Trends & Global Forecasts to 2017.All research reports from MarketsandMarkets
provide detailed tables and forecasts following extensive interviews with
market participants.

Browse related reports

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq,
Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq,
ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)]
- Global Forecast to 2017

http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy,
Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray
Crystallography) - Instruments, Reagents & Services - Trends & Global
Forecasts to 2017

http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in
the U.S. We publish strategically analyzed market research reports and serve
as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services. MarketsandMarkets covers thirteen
industry verticals; including advanced materials, automotives and
transportation, banking and financial services, biotechnology , healthcare
information technology, chemicals, consumer goods, telecommunications and IT,
energy and power, food and beverages, industrial automation, medical devices,
pharmaceuticals,agriculture industry, semiconductor and electronics,
aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

Contact: Mr.Rohan North - Dominion Plaza 17304 Preston Road Suite
800,Dallas, TX75252 Tel: +1-888-600-6441 Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @
http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @
http://www.linkedin.com/company/marketsandmarkets